22nd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) Dec 12 - Dec 14, 2024 Supporting Materials Investigating the Effects of Icovamenib on Poorly Managed Severe Insulin-Deficient Diabetes (SIDD): Insights from COVALENT-111 Case Studies Poster Presentation: December 12, 2024, at 6:30pm – 7:30pm PST 748.7 KB Unlocking the Potential of Menin Inhibition: Icovamenib and a look into the Future of Diabetes Management Breakfast Symposium: December 13, 2024, at 7:00am – 7:45am PST 7.5 MB Combination of Icovamenib and GLP-1-Based Therapeutic Agents Improves Beta Cell Function and Insulin Secretion Oral Presentation: December 13th, 2024, at 7:30pm – 9:00pm PST 1.6 MB
Investigating the Effects of Icovamenib on Poorly Managed Severe Insulin-Deficient Diabetes (SIDD): Insights from COVALENT-111 Case Studies Poster Presentation: December 12, 2024, at 6:30pm – 7:30pm PST 748.7 KB
Unlocking the Potential of Menin Inhibition: Icovamenib and a look into the Future of Diabetes Management Breakfast Symposium: December 13, 2024, at 7:00am – 7:45am PST 7.5 MB
Combination of Icovamenib and GLP-1-Based Therapeutic Agents Improves Beta Cell Function and Insulin Secretion Oral Presentation: December 13th, 2024, at 7:30pm – 9:00pm PST 1.6 MB
